SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

DE LA TORRE AGUILAR, M.ª J. et al. Perfil de ácidos grasos en pacientes oncológicos pediátricos. Nutr. Hosp. [online]. 2012, vol.27, n.2, pp.617-622. ISSN 0212-1611.

    1. López Galindo MA, Carrero Caballero MC, Sánchez García MJ. Aspectos a considerar en el tratamiento oncológico infantil. El dolor ante el acceso venoso. Experiencia pionera en el Hospital Ramón y Cajal de Madrid. Revista on-line Terapia intravenosa 2009; Vol 1: Núm 1. [ Links ]

    2. Sala A, Rossi E, Antillon F, Molina AL, de Maselli T, Bonilla M, Hernandez A, Ortiz R, Pacheco C, Nieves R, Navarrete M, Barrantes M, Pencharz P, Valsecchi MG, Barr R. Nutritional status at diagnosis is related to clinical outcomes in children and adolescents with cancer: A perspective from Central América. Eur J Cancer 2011 Jul 5. In press. [ Links ]

    3. Sierrasesumaga L. Soporte nutricional en el niño con cáncer. En: Bueno M, Sarria A, Pérez González JM. Nutrición en Pediatría. Ergon. Madrid. 2a ed. 2003, 435-444. [ Links ]

    4. Kuliszkiewicz-Janus M, Melecki R, Mohamed AS. Lipid changes occurring in the course of hematological cancer. Cell Moll Biol Lett 2008; 13: 465-474. [ Links ]

    5. Moschovi M, Trimis G, Apostolakou F, Papassotiriou I, Tzortzatou-Stathopoulou F. Serum lipid alterations in acute lymphoblastic leukemia of childhood. J Pediatr Hematol Oncol 2004; 26 (5): 289-93. [ Links ]

    6. Greene ER, Huang S, Serhan CN, Panigrahy D. Regulation of inflammation in cancer by eicosanoids. Prostaglandins Other Lipid Mediat 2011; 96 (1-4): 27-36. [ Links ]

    7. Bougnoux P, Hajjaji N, Maheo K, Covet C, Chevalier S. Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth. Prog Lipid Rest 2010; 49 (1): 76-86. [ Links ]

    8. Kumar NB, Kazi A, Smith T, Crocker T, Yu D, Reich RR, Reddy K, Hastings S, Exterman M, Balducci L, Dalton K, Bepler G. Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment. Curr Treat Options Oncol 2010; 11 (3-4): 107-17. [ Links ]

    9. Blaauwbroek R, Groenier KH, Kamps WA, Meyboom-de Jong B, Postma A. Late effects in adult survivors of childhood cancer: the need for life-long follow-up. Ann Oncol 2007; 18 (11): 1898-902. [ Links ]

    10. Gil-Campos M, del Carmen Ramírez-Tortosa M, Larqué E, Linde J, Aguilera CM, Cañete R, Gil A. Metabolic syndrome affects fatty acid composition of plasma lipids in obese prepubertal children. Lipids 2008; 43 (8): 723-32. [ Links ]

    11. Zacarías I. Capitulo 9 Métodos de evaluación dietética. En: Producción y manejo de datos de composición química de alimentos en nutrición. Eds. Morón C, Zacarías I, de Pablos S. 1997, Santiago (Chile), Univ. Chile. [ Links ]

    12. Food and Nutrition Board. Institute of Medicine. Dietary Reference Intakes (DRI) for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. Washington: National Academy Press; 2002. [ Links ]

    13. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetología 1985; 28: 412-9. [ Links ]

    14. Kolarovic L, Fournier NC. Anal Biochem. A comparison of extraction methods for the isolation of phospholipids from biological sources. 1986; 156 (1): 244-50. [ Links ]

    15. Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J. Lipid Res 1986; 27: 114-120. [ Links ]

    16. Argilés JM, Busquets S, García-Martínez C, López-Soriano FJ. Mediators involved in the cancer anorexia-cachexia syndrome: past, present, and future. Nutrition 2005; 21 (9): 977-85. [ Links ]

    17. Murphy AJ, White M, Davies PS. The validity of simple methods to detect poor nutritional status in paediatric oncology patients. Ann Oncol 2007; 18 (11): 1898-902. [ Links ]

    18. Andreoli A, De Lorenzo A, Cadeddu F, Iacopino L, Grande M. New trends in nutritional status assessment of cancer patients. Eur Rev Med Pharmacol Sci. 2011; 15 (5): 469-80. [ Links ]

    19. Martin E, Belleton F, Lallemand Y, Goy F, Pérol D, Bachmann P, Marec-Bérard P. Malnutrition in pediatric oncology: prevalence and screening. Arch Pediatr 2006; 13 (4): 352-7. [ Links ]

    20. Williams R, Hinds PS, Ke W, Hu XJ. A comparison of calorie and protein intake in hospitalized pediatric oncology patients dining with a caregiver versus patients dining alone: a randomized, prospective clinical trial. J Pediatr Oncol Nurs 2004; 21 (4): 223-321. [ Links ]

    21. Michon J. Incidence of anemia in pediatric cancer patients in Europe: results of a large, international survey. Med Pediatr Oncol 2002; 39 (4): 448-50. [ Links ]

    22. Baicus C, Caraiola S, Rimbas M, Patrascu R, Baicus A; for Grupul de Studiu al Scaderii Ponderale Involuntare. Utility of routine hematological and inflammation parameters for the diagnosis of cancer in involuntary weight loss. J Investig Med 2011; 59 (6): 951-5. [ Links ]

    23. Hafiz MG, Mannan MA. Nutritional status at initial presentation in childhood acute lymphoblastic leukemia and its effect on induction of remission. Mymensingh Med J 2008; 17 (Suppl. 2): S46-51. [ Links ]

    24. White M, Davies P, Murphy A. Validation of percent body fat indicators in pediatric oncology nutrition assessment. J Pediatr Hematol Oncol 2008; 30 (2): 124-9. [ Links ]

    25. Dávila-Rodríguez MI, Novelo-Huerta HI, Márquez-Solís R, Cortés-Gutiérrez E, Pérez-Cortés P, Cerda-Flores RM. Nutritional indicators in children with acute lymphoblastic leukemia. Rev Med Inst Mex Seguro Soc 2010; 48 (6): 639-44. [ Links ]

    26. Moschovi M, Trimis G, Apostolakou F, Papassotiriou I, Tzortzatou-Stathopoulou F. Serum lipid alterations in acute lymphoblastic leukemia of childhood. J Pediatr Hematol Oncol 2004; 26 (5): 289-93. [ Links ]

    27. Gil-Campos M, Dalmau Serra J; Comité de Nutrición de la Asociación Española de Pediatría. Importance of docosahexaenoic acid (DHA): Functions and recommendations for its ingestion in inf; An Pediatr (Barc) 2010; 73 (3): 142.e1-8. [ Links ]

    28. Pratt VC, Watanabe S, Bruera E, Mackey J, Clandinin MT, Baracos VE, Field CJ Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation. Br J Cancer 2002; 87 (12): 1370-8. [ Links ]

    29. Cvetkovi Z, Vuci V, Cvetkovi B, Petrovi M, Risti-Medi D, Tepsi J, Glibeti M. Abnormal fatty acid distribution of the serum phospholipids of patients with non-Hodgkin lymphoma. Ann Hematol 2010; 89 (8): 775-82. [ Links ]

    30. Gleissman H, Yang R, Martinod K, Lindskog M, Serhan CN, Johnsen JI, Kogner P Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates. FASEB J 2010; 24 (3): 906-15. [ Links ]

    31. Gleissman H, Segerström L, Hamberg M, Ponthan F, Lindskog M, Johnsen JI, Kogner P Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo. Int J Cancer 2011; 128 (7): 1703-11. [ Links ]

    32. Lindskog M, Gleissman H, Ponthan F, Castro J, Kogner P, Johnsen JI. Neuroblastoma cell death in response to docosahexaenoic acid: sensitization to chemotherapy and arsenic-induced oxidative stress. Int J Cancer 2006; 118 (10): 2584-93. [ Links ]